The analytical review of the domestic market of etherosorbents

Abstract

Aim. To analyze the registered enterosorbents, pharmaceutical substances for their production, as well as sorptive dietary supplements in order to determine the feasibility of creating and organizing the production of new enterosorbents on the basis of natural zeolite (clinoptilolite).Materials and methods. The list of medicines based on official sources of information was used in the work; it was processed by generalization, systematization, graphic methods, as well as methods of comparative and structural analysis.Results. The analysis of the pharmaceutical market of Ukraine concerning the range of the registered pharmaceutical substances, medicinal products and dietary supplements with the enterosorption action has been conducted. Structuring of the selected list of medicines by the production basis, the number of components and the type of dosage form has been carried out. By the production basis the majority of medicines are of domestic production (71.73 %). The registered medicines are monocomponent by the composition, and most dietary supplements are complex (69.93 %). It has been determined that solid dosage forms of medicines (76.22 %) and dietary supplements (95.23 %) are the most widely represented. Moreover, the natural zeolite at the pharmaceutical market is represented by dietary supplements of foreign production.Conclusions. The absence of domestic zeolite preparations (clinoptilolite) at the Ukrainian market and the presence of only dietary supplements of foreign origin indicate 100% monopolization in this segment of the market, and therefore, the necessity and expediency of introducing new domestic medicines of enterosorbents on the basis of natural zeolite into the market.